Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal O Nowicki

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
DNA Repair|November 22, 2005
BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cellsArtur Slupianek, Michal O Nowicki, Mateusz Koptyra, et al.
Cancers|April 17, 2019
Proteomic Analysis Implicates Vimentin in Glioblastoma Cell MigrationMichal O Nowicki, Josie L Hayes, E Antonio Chiocca, et al.
Journal of Theoretical Biology|July 15, 2009
A mathematical model for pattern formation of glioma cells outside the tumor spheroid coreYangjin Kim, Sean Lawler, Michal O Nowicki, et al.
Cell Cycle (Georgetown, Tex.)|July 22, 2010
microRNA-451: A conditional switch controlling glioma cell proliferation and migrationJakub Godlewski, Agnieszka Bronisz, Michal O Nowicki, et al.
Advanced Biosystems|May 9, 2020
Immune Escape Mediated by Exosomal PD-L1 in CancerSean E Lawler, Michal O Nowicki, Franz L Ricklefs, et al.
Non-Coding RNA|March 17, 2019
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional TherapyDaisuke Ogawa, Khairul Ansari, Michal O Nowicki, et al.
Journal of Neuro-Oncology|October 13, 2010
The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cellsAdriana Estrada-Bernal, Sean E Lawler, Michal O Nowicki, et al.
Cell Cycle (Georgetown, Tex.)|October 20, 2004
BCR/ABL recruits p53 tumor suppressor protein to induce drug resistanceTomasz Stoklosa, Artur Slupianek, Mandrita Datta, et al.
Oncogene|March 8, 2005
BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatinArtur Slupianek, Ewa Gurdek, Mateusz Koptyra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
ICP0 inhibits the decrease of HSV amplicon-mediated transgene expressionMasataka Suzuki, Kazue Kasai, Akihiro Ohtsuki, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
DNA Repair|November 22, 2005
BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cellsArtur Slupianek, Michal O Nowicki, Mateusz Koptyra, et al.
Cancers|April 17, 2019
Proteomic Analysis Implicates Vimentin in Glioblastoma Cell MigrationMichal O Nowicki, Josie L Hayes, E Antonio Chiocca, et al.
Journal of Theoretical Biology|July 15, 2009
A mathematical model for pattern formation of glioma cells outside the tumor spheroid coreYangjin Kim, Sean Lawler, Michal O Nowicki, et al.
Cell Cycle (Georgetown, Tex.)|July 22, 2010
microRNA-451: A conditional switch controlling glioma cell proliferation and migrationJakub Godlewski, Agnieszka Bronisz, Michal O Nowicki, et al.
Advanced Biosystems|May 9, 2020
Immune Escape Mediated by Exosomal PD-L1 in CancerSean E Lawler, Michal O Nowicki, Franz L Ricklefs, et al.
Non-Coding RNA|March 17, 2019
MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional TherapyDaisuke Ogawa, Khairul Ansari, Michal O Nowicki, et al.
Journal of Neuro-Oncology|October 13, 2010
The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cellsAdriana Estrada-Bernal, Sean E Lawler, Michal O Nowicki, et al.
Cell Cycle (Georgetown, Tex.)|October 20, 2004
BCR/ABL recruits p53 tumor suppressor protein to induce drug resistanceTomasz Stoklosa, Artur Slupianek, Mandrita Datta, et al.
Oncogene|March 8, 2005
BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatinArtur Slupianek, Ewa Gurdek, Mateusz Koptyra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 19, 2009
ICP0 inhibits the decrease of HSV amplicon-mediated transgene expressionMasataka Suzuki, Kazue Kasai, Akihiro Ohtsuki, et al.
Pageof 5